Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FIFTH THIRD BANCORPFITB · Entity 3034 | EVP | February 19, 2025 | February 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FIFTH THIRD BANCORP
Report date February 19, 2025 · Filed February 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 139,828 |
Reported balance
After 2025-02-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-02-19 · Grant · Acquired 18,399 · Balance 139,828 F1: Restricted Stock Units granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in three equal annual installments beginning on the first anniversary of the grant date. F2: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. |
| Common StockSEC Table I · non-derivative | Direct | 161,380 |
Reported balance
After 2025-02-19 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-02-19 · Grant · Acquired 21,552 · Balance 161,380 F3: Performance Share award received upon satisfaction of performance criteria subject to vesting on February 19, 2025. F2: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. |
| Common StockSEC Table I · non-derivative | Direct | 152,556 |
Reported balance
After 2025-02-19 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2025-02-19 · Tax withholding · Disposed 8,824 · Balance 152,556 F4: Shares withheld for taxes upon the vesting performance shares granted to the reporting person. |
| Common StockSEC Table I · non-derivative | Direct | 130,856 |
Reported balance
After 2025-02-20 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2025-02-20 · Sale · Disposed 21,700 · Balance 130,856 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.25 to $43.81, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in three equal annual installments beginning on the first anniversary of the grant date.
F2: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid.
F3: Performance Share award received upon satisfaction of performance criteria subject to vesting on February 19, 2025.
F4: Shares withheld for taxes upon the vesting performance shares granted to the reporting person.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.25 to $43.81, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMSURG CORP
Report date December 01, 2016 · Filed December 01, 2016
Section 16 reporting ended · disclosed 2016-12-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-01 transaction · row 1
1 source rowRow 1 · 2016-12-01 · Disposition to issuer · Disposed 12,180 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.
F2: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
Envision Healthcare Corp
Report date October 11, 2018 · Filed October 15, 2018
Section 16 reporting ended · disclosed 2018-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-11 transaction · row 1
1 source rowRow 1 · 2018-10-11 · Disposition to issuer · Disposed 19,321 · Balance 0 F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. |
Filing footnotes · ownership attribution and instrument terms
F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes.
F2: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 4, 2021 20:24 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | SaleCommon Stock | 1,414 | $40.48 | $57,241.55 |
DisclosureSEC source: 0000035527-21-000172 · wf-form4_162015985523886.xml · nonDerivative · entry 4 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,335 Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:24 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 4,873 | $40.47 | $197,210.31 |
DisclosureSEC source: 0000035527-21-000172 · wf-form4_162015985523886.xml · nonDerivative · entry 3 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,749 Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:24 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Exercise / conversionCommon Stock | 7,182 | $19.01 | $136,529.82 |
DisclosureSEC source: 0000035527-21-000172 · wf-form4_162015985523886.xml · nonDerivative · entry 2 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:24 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | SaleCommon Stock | 8,040 | $40.66 | $326,866.20 |
DisclosureSEC source: 0000035527-21-000172 · wf-form4_162015985523886.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,440 Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 21:05 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 1,558 | $36.34 | $56,617.72 |
DisclosureSEC source: 0000035527-21-000119 · wf-form4_161670631834895.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,480.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on March 23, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:32 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | GrantStock Appreciation Right · Derivative | 21,046 | $0.00 Strike: $33.53 | $0.00 |
DisclosureSEC source: 0000035527-21-000085 · wf-form4_161377036270938.xml · derivative · entry 2 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,046 Underlying: Common Stock · 21,046 shares Expires 2031-02-17 F3 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. F2 · derivative.exercise_date: Indicates grant date. Stock appreciation rights are exercisable in thirds beginning on the first anniversary of the grant date with one-third of the total grant vesting annually over a three-year period. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:32 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | GrantCommon Stock | 11,482 | $0.00 | $0.00 |
DisclosureSEC source: 0000035527-21-000085 · wf-form4_161377036270938.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,038.3587 F1 · security: Restricted Stock award granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:12 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 743 | $32.51 | $24,154.93 |
DisclosureSEC source: 0000035527-21-000072 · wf-form4_161359988806561.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,556.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 12, 2020. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:36 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 721 | $32.10 | $23,144.10 |
DisclosureSEC source: 0000035527-21-000052 · wf-form4_161290655653631.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,299.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 6, 2019. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:21 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 341 | $31.03 | $10,581.23 |
DisclosureSEC source: 0000035527-21-000040 · wf-form4_161256010677754.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,020.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 3, 2017. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 22:38 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 316 | $28.93 | $9,141.88 |
DisclosureSEC source: 0000035527-21-000028 · wf-form4_161230548211726.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,361.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on January 29, 2018. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:24 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | SaleCommon Stock | 8,500 | $25.81 | $219,385.00 |
DisclosureSEC source: 0000035527-20-000126 · wf-form4_160625304660720.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,677.3587 Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 20:04 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Exercise / conversionStock Appreciation Right · Derivative | 10,653 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0000035527-20-000103 · wf-form4_160391543472003.xml · derivative · entry 3 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,653 shares Expires 2026-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Due to a clerical error, the Reporting Owner's Form 3 filed on February 6, 2020 described the Date Exercisable and Expiration Date for the Stock Appreciation Right as April 15, 2016 and April 15, 2026, respectively, rather than April 19, 2016 and April 19, 2026, respectively. F3 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. F2 · derivative.exercise_date: Indicates grant date. Stock appreciation rights are exercisable in fourths beginning on the first anniversary of the grant date with one-fourth of the total grant vesting annually over a four-year period. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 20:04 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 9,182 | $23.45 | $215,317.90 |
DisclosureSEC source: 0000035527-20-000103 · wf-form4_160391543472003.xml · nonDerivative · entry 2 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,177.3587 Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 20:04 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Exercise / conversionCommon Stock | 10,653 | $18.11 | $192,925.83 |
DisclosureSEC source: 0000035527-20-000103 · wf-form4_160391543472003.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,359.3587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2020 Filed Apr 20, 2020 20:02 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 894 | $16.63 | $14,867.22 |
DisclosureSEC source: 0000035527-20-000055 · edgar.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,706.3587 F1 · shares: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on April 19, 2016. Read SEC document |
| March 23, 2020 Filed Mar 31, 2020 20:02 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | GrantCommon Stock | 13,495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000035527-20-000039 · edgar.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,185.3587 F1 · security: Restricted Stock Units granted pursuant to FIfth Third Bancorp Incentive Compensation Plan subject to vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 22:42 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | GrantCommon Stock | 13,495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-004720 · doc4.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,690.3587 F1 · security: Restricted Stock granted pursuant to Fifth Third Bancorp Incentive Compensation Plan subject to vesting in four equal annual installments beginning on the first anniversary of the grant date F2 · price: Granted pursuant to Fifth Third Bancorp Incentive Compensation Plan. No consideration paid. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:12 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 721 | $29.66 | $21,384.86 |
DisclosureSEC source: 0000035527-20-000024 · edgar.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,195.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 6, 2019. Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 22:13 UTC | FIFTH THIRD BANCORP FITB · Entity 3034 | Tax withholdingCommon Stock | 342 | $28.98 | $9,911.16 |
DisclosureSEC source: 0000035527-20-000020 · edgar.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,916.3587 F1 · kind: Shares withheld for taxes upon the vesting of restricted stock units granted to the reporting person on February 3, 2017. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 16:53 UTC | Envision Healthcare Corp EVHC · Entity 162981 | Disposition to issuerCommon Stock | 19,321 | $46.00 | $888,766.00 |
DisclosureSEC source: 0001678531-18-000150 · wf-form4_153962238467230.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2 · shares: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. F1 · price: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. Read SEC document |
| May 25, 2018 Filed May 29, 2018 22:16 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 4,017 | $43.57 | $175,020.69 |
DisclosureSEC source: 0001678531-18-000082 · wf-form4_152763217624588.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,321 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document |
| May 25, 2017 Filed May 30, 2017 23:38 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 3,124 | $56.03 | $175,037.72 |
DisclosureSEC source: 0001678531-17-000133 · wf-form4_149618751833417.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,304 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 16:36 UTC | AMSURG CORP AMSG · Entity 180763 | Disposition to issuerCommon stock | 12,180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000895930-16-000292 · wf-form4_148062817648216.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:59 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 12,180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-16-000068 · wf-form4_148071592857341.xml · nonDerivative · entry 1 Lavender Kevin P · CIK 0001291607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,180 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of AmSurg Corp. common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by the Company and converted into one share of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to AmSurg Corp. plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that AmSurg Corp.'s outstanding performance awards issued pursuant to the Performance Share Unit Award Agreement (the "Agreement") under its 2014 Equity and Incentive Plan (the "Plan") that were eligible to vest settled into shares of restricted stock at the Target Award (as defined in the Agreement) upon consummation of the Mergers, as the Mergers constituted a Change of Control (as defined in the Plan). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.